Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 33 out of 100. Biomarkers

Topic: Amyloid, tau and blood-test diagnosis

Results We determined that several iterations of the discriminant analysis improved the classification of subjects into the AβL and AβH groups. We found that an ROI consisting of the posterior cingulate cortex/precuneus and the medial frontal cortex yielded optimal group separation and showed good stability across different reference regions and cognitive cohorts.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Carbonell, F., Zijdenbos, A. P., Charil, A., Grand'Maison, M., Bedell, B. J., & Alzheimer’s Disease Neuroimaging Initiative. (2015). Optimal Target Region for Subject Classification on the Basis of Amyloid PET Images. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.115.158774

Vancouver

Carbonell F, Zijdenbos AP, Charil A, Grand'Maison M, Bedell BJ, Alzheimer’s Disease Neuroimaging Initiative. Optimal Target Region for Subject Classification on the Basis of Amyloid PET Images. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2015. doi:10.2967/jnumed.115.158774. PMID: 26135108.

BibTeX

@article{carbonell2015-26135108,
  author  = {Carbonell, F. and Zijdenbos, A. P. and Charil, A. and Grand'Maison, M. and Bedell, B. J. and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{Optimal Target Region for Subject Classification on the Basis of Amyloid PET Images}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2015},
  doi     = {10.2967/jnumed.115.158774},
  pmid    = {26135108},
  url     = {https://doi.org/10.2967/jnumed.115.158774}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This methods study found that a specific brain region combining the posterior cingulate cortex/precuneus and medial frontal cortex best separated people into low and high amyloid groups on amyloid PET. It concerns how to classify scans and does not test a treatment or prevention for Alzheimer disease.

Study details

How this study scored 33/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 3 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 2 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 33 of 100.33 of 100 points earned67 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Journal of nuclear medicine : official publication, Society of Nuclear Medicine)
Journal's citation record 2 / 4 Journal of Nuclear Medicine: journal h-index 230 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 2015 — within 20 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 3 / 7 Cited 19 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.5 citations a year over 13 year(s) since 2015
Impact for its field and year 2 / 6 Cited 1.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 2 / 6 Cited by 3 other studies in this library
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Barry J. Bedell: h-index 28 (OpenAlex, whole career)
Institution's track record 0 / 3 Research Institute of the McGill University Health Centre: institution h-index 328 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 26135108)
Free to read 0 / 2 Behind a paywall — scores zero
Total 33 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — Unpaywall lists this copy as free to read: the link above (checked 10 Oct 2026).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 17.

Later studies that cite this one

3 studies in the alzhub library list this one in their references.

Related studies in Biomarkers

Also tagged “machine”

835 studies in the library carry the topic tag “machine”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 835 tagged studies.

Similar studies

More on Biomarkers

See all studies in Biomarkers →